| PERIOD ENDING | 1-Nov-09 | 2-Nov-08 | 31-Oct-07 | | Total Revenue | 1,484,000 | 1,699,000 | 1,527,000 | | Cost of Revenue | 924,000 | 1,044,000 | 1,165,000 | | | Gross Profit | 560,000 | 655,000 | 362,000 | | | Operating Expenses | | Research Development | 245,000 | 265,000 | 205,000 | | Selling General and Administrative | 223,000 | 196,000 | 193,000 | | Non Recurring | 23,000 | 6,000 | 41,000 | | Others | 21,000 | 28,000 | 28,000 | | | | Total Operating Expenses | 512,000 | 495,000 | 467,000 | | | | Operating Income or Loss | 48,000 | 160,000 | (105,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,000) | (14,000) | 2,000 | | Earnings Before Interest And Taxes | 41,000 | 146,000 | (103,000) | | Interest Expense | 77,000 | 86,000 | 109,000 | | Income Before Tax | (36,000) | 60,000 | (212,000) | | Income Tax Expense | 8,000 | 3,000 | 8,000 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (44,000) | 57,000 | (220,000) | | | Non-recurring Events | | Discontinued Operations |
-
| 26,000 | 61,000 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (44,000) | 83,000 | (159,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($44,000) | $83,000 | ($159,000) |
|
0.02% Nasdaq 
0.33%
Income Statement
